Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 14 | 2022 | 642 | 2.900 |
Why?
|
| Smoking Cessation | 6 | 2022 | 316 | 1.980 |
Why?
|
| Tobacco Use Disorder | 3 | 2021 | 184 | 1.500 |
Why?
|
| Smoking | 6 | 2022 | 556 | 1.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2019 | 164 | 0.790 |
Why?
|
| Esophagectomy | 2 | 2021 | 34 | 0.770 |
Why?
|
| Counseling | 2 | 2021 | 149 | 0.640 |
Why?
|
| Smoke | 1 | 2017 | 20 | 0.630 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 24 | 0.580 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2016 | 28 | 0.580 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2015 | 56 | 0.520 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 162 | 0.490 |
Why?
|
| Bronchi | 1 | 2014 | 51 | 0.480 |
Why?
|
| Trachea | 1 | 2014 | 51 | 0.480 |
Why?
|
| Surgical Flaps | 1 | 2014 | 135 | 0.450 |
Why?
|
| Guideline Adherence | 1 | 2013 | 148 | 0.430 |
Why?
|
| Mass Screening | 1 | 2015 | 370 | 0.420 |
Why?
|
| Humans | 27 | 2022 | 54284 | 0.400 |
Why?
|
| Pneumonectomy | 2 | 2010 | 27 | 0.400 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2010 | 2 | 0.390 |
Why?
|
| Professional Practice | 1 | 2010 | 21 | 0.390 |
Why?
|
| Epidemics | 1 | 2010 | 19 | 0.380 |
Why?
|
| Internationality | 1 | 2010 | 49 | 0.380 |
Why?
|
| Thoracotomy | 1 | 2010 | 37 | 0.380 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 31 | 0.380 |
Why?
|
| Coronary Disease | 1 | 2011 | 169 | 0.370 |
Why?
|
| HIV Infections | 1 | 2013 | 394 | 0.350 |
Why?
|
| Osteosarcoma | 1 | 2009 | 37 | 0.330 |
Why?
|
| Catheter Ablation | 1 | 2010 | 131 | 0.330 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 197 | 0.310 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 193 | 0.290 |
Why?
|
| Risk Factors | 3 | 2020 | 3935 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 69 | 0.220 |
Why?
|
| Microdissection | 1 | 2022 | 24 | 0.210 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2014 | 116 | 0.200 |
Why?
|
| Male | 9 | 2017 | 27334 | 0.190 |
Why?
|
| Equipment Failure | 1 | 2021 | 70 | 0.190 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 100 | 0.180 |
Why?
|
| Tobacco Products | 1 | 2021 | 115 | 0.170 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2017 | 13 | 0.160 |
Why?
|
| Kentucky | 1 | 2017 | 72 | 0.160 |
Why?
|
| Risk Reduction Behavior | 1 | 2018 | 70 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 171 | 0.150 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2017 | 37 | 0.150 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 166 | 0.150 |
Why?
|
| Female | 8 | 2017 | 28441 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 150 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2018 | 249 | 0.140 |
Why?
|
| Recurrence | 1 | 2018 | 690 | 0.140 |
Why?
|
| Gambling | 1 | 2015 | 19 | 0.140 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 28 | 0.140 |
Why?
|
| Particulate Matter | 1 | 2015 | 56 | 0.130 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 71 | 0.130 |
Why?
|
| Cough | 2 | 2017 | 55 | 0.130 |
Why?
|
| Intercostal Muscles | 1 | 2014 | 4 | 0.130 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2014 | 10 | 0.130 |
Why?
|
| Patient Handoff | 1 | 2014 | 15 | 0.120 |
Why?
|
| Incidence | 1 | 2017 | 1082 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 397 | 0.120 |
Why?
|
| Aged | 4 | 2016 | 10054 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5604 | 0.120 |
Why?
|
| SEER Program | 1 | 2013 | 91 | 0.120 |
Why?
|
| Health Policy | 1 | 2014 | 171 | 0.120 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 806 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 543 | 0.110 |
Why?
|
| United States | 2 | 2014 | 5217 | 0.110 |
Why?
|
| Arkansas | 2 | 2015 | 2100 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 1213 | 0.110 |
Why?
|
| Trauma Centers | 1 | 2014 | 218 | 0.110 |
Why?
|
| Medicare | 1 | 2013 | 241 | 0.100 |
Why?
|
| Comorbidity | 1 | 2013 | 663 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1316 | 0.100 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 8 | 0.100 |
Why?
|
| Pulmonary Circulation | 1 | 2010 | 36 | 0.100 |
Why?
|
| Stereotyping | 1 | 2010 | 41 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 104 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 321 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 492 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1228 | 0.090 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 10 | 0.090 |
Why?
|
| Mesothelioma | 1 | 2009 | 19 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 3431 | 0.090 |
Why?
|
| Endosonography | 1 | 2009 | 96 | 0.080 |
Why?
|
| Nicotine | 1 | 2010 | 207 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2019 | 52 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 146 | 0.080 |
Why?
|
| Pain | 1 | 2010 | 405 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 216 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 644 | 0.060 |
Why?
|
| Middle Aged | 4 | 2017 | 13088 | 0.060 |
Why?
|
| Adult | 3 | 2017 | 14207 | 0.060 |
Why?
|
| Antigens | 1 | 2022 | 53 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 89 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 67 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2022 | 35 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2022 | 56 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 49 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2907 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 310 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 531 | 0.050 |
Why?
|
| Infant | 1 | 2009 | 3817 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2009 | 4147 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6432 | 0.040 |
Why?
|
| Weight Loss | 1 | 2021 | 271 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 581 | 0.040 |
Why?
|
| Keratins | 1 | 2017 | 33 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2017 | 46 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 60 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2017 | 48 | 0.040 |
Why?
|
| Adolescent | 1 | 2009 | 6897 | 0.040 |
Why?
|
| Fever | 1 | 2017 | 129 | 0.040 |
Why?
|
| Pneumonia | 1 | 2017 | 129 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 599 | 0.040 |
Why?
|
| Public Facilities | 1 | 2015 | 4 | 0.030 |
Why?
|
| Child | 1 | 2009 | 7341 | 0.030 |
Why?
|
| Mutation | 1 | 2022 | 1501 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 322 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2017 | 389 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1089 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1033 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 47 | 0.030 |
Why?
|
| Patient Care | 1 | 2014 | 61 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2014 | 79 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 808 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 2009 | 3 | 0.020 |
Why?
|
| Pleura | 1 | 2009 | 15 | 0.020 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2009 | 11 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 256 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 923 | 0.020 |
Why?
|